Science and Technology
AI-Powered Moderna Cancer Vaccine Shows Promise in Phase 3 Trial, Elon Musk Reacts
Moderna and Merck report positive Phase 3 results for an AI-assisted personalised mRNA cancer vaccine for melanoma, as Elon Musk calls…
2 stories
Moderna and Merck report positive Phase 3 results for an AI-assisted personalised mRNA cancer vaccine for melanoma, as Elon Musk calls…
ICMR has licensed the anti-HPV drug candidate SHetA2 to Emcure Pharmaceuticals. The therapy could offer a non-surgical treatment for stage…
The stories that matter, in your inbox by 8 AM. Free, no spam.